日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion

MPS-Authors
/persons/resource/persons290564

Kawase,  H
Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224211

Wettschureck,  Nina
Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224185

Offermanns,  Stefan
Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;

/persons/resource/persons224197

Takefuji,  Mikito
Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;

External Resource
There are no locators available
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)
公開されているフルテキストはありません
付随資料 (公開)
There is no public supplementary material available
引用

Yoshida, S., Yoshida, T., Inukai, K., Kato, K., Yura, Y., Hattori, T., Enomoto, A., Ohashi, K., Okumura, T., Ouchi, N., Kawase, H., Wettschureck, N., Offermanns, S., Murohara, T., & Takefuji, M. (2024). Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion. NATURE COMMUNICATIONS, 15(1):. doi:10.1038/s41467-024-52068-0.


引用: https://hdl.handle.net/21.11116/0000-0010-08B1-D
要旨
Chronic fibrotic tissue disrupts various organ functions. Despite
significant advances in therapies, mortality and morbidity due to heart
failure remain high, resulting in poor quality of life. Beyond the
cardiomyocyte-centric view of heart failure, it is now accepted that
alterations in the interstitial extracellular matrix (ECM) also play a
major role in the development of heart failure. Here, we show that
protein kinase N (PKN) is expressed in cardiac fibroblasts. Furthermore,
PKN mediates the conversion of fibroblasts into myofibroblasts, which
plays a central role in secreting large amounts of ECM proteins via p38
phosphorylation signaling. Fibroblast-specific deletion of PKN led to a
reduction of myocardial fibrotic changes and cardiac dysfunction in mice
models of ischemia-reperfusion or heart failure with preserved ejection
fraction. Our results indicate that PKN is a therapeutic target for
cardiac fibrosis in heart failure.